Evidence map›Paper›PMID 39501712›Full record

ArticleStatistical methods in medical research2024

A Bayesian method for adverse effects estimation in observational studies with truncation by death.

Anthony Sisti, Andrew Zullo, Roee Gutman

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anthony SistiDepartment of Biostatistics, Brown University, Providence, RI, USA.ORCID 0000-0001-8433-5120
Andrew ZulloDepartment of Epidemiology, Brown University, Providence, RI, USA.
Roee GutmanDepartment of Biostatistics, Brown University, Providence, RI, USA.

Funding

VARIATIONS IN LIFE'S FINAL CHAPTERP01AG027296 · NIA · BROWN UNIVERSITY · PI AMAL N. TRIVEDI, Kali St. Marie Thomas · 2007 to 2026
$38.9M
NIA NIH HHS P01 AG027296
6 · The paper itself

Abstract

Death among subjects is common in observational studies evaluating the causal effects of interventions among geriatric or severely ill patients. High mortality rates complicate the comparison of the prevalence of adverse events between interventions. This problem is often referred to as outcome "truncation" by death. A possible solution is to estimate the survivor average causal effect, an estimand that evaluates the effects of interventions among those who would have survived under both treatment assignments. However, because the survivor average causal effect does not include subjects who would have died under one or both arms, it does not consider the relationship between adverse events and death. We propose a Bayesian method which imputes the unobserved mortality and adverse event outcomes for each participant under the intervention they did not receive. Using the imputed outcomes we define a composite ordinal outcome for each patient, combining the occurrence of death and the adverse event in an increasing scale of severity. This allows for the comparison of the effects of the interventions on death and the adverse event simultaneously among the entire sample. We implement the procedure to analyze the incidence of heart failure among geriatric patients being treated for Type II diabetes with sulfonylureas or dipeptidyl peptidase-4 inhibitors.

Indexed as

Bayes TheoremDiabetes Mellitus, Type 2Heart FailureObservational Studies as TopicAgedHumansHypoglycemic AgentsModels, StatisticalSulfonylurea CompoundsHypoglycemic AgentsSulfonylurea Compoundsadverse eventsComposite endpointmultiple imputationpropensity scorereal-world evidence

Identifiers

PMID39501712
PMCPMC11955163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.